» Articles » PMID: 34475765

Prevalence of Hepatitis E Virus Infection Among Blood Donors in the Eastern Province of Saudi Arabia

Overview
Publisher Dove Medical Press
Specialty Health Services
Date 2021 Sep 3
PMID 34475765
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Hepatitis E virus (HEV) causes acute hepatitis in humans and constitutes a major problem for immunocompromised patients, patients with hematological diseases, and pregnant women. It is transmitted mainly through fecal oral route; however, transmission through blood and blood products is reported globally and becoming a health concern. We sought to determine the prevalence of HEV among blood donors in the Eastern Province of Saudi Arabia using molecular as well as serological assays to assess the safety of blood transfusion and the need for HEV screening among blood donors.

Patients And Methods: A total of 806 whole blood samples were collected from blood donors between May and November 2020 and tested for anti-HEV IgG and IgM antibodies by ELISA and for HEV RNA by RT-PCR.

Results: The overall seroprevalence of HEV IgG antibodies was 3.2% with no statistically significant difference between the non-Saudis (3.28%) and Saudis (3.17%) (p value 0.929) or between males (3.14%) and females (4.88%) (p value 0.527). None of the IgG positive individuals had IgM antibodies. HEV RNA was not detected in any of the blood donors.

Conclusion: HEV seroprevalence is low among blood donors in the Eastern Province of Saudi Arabia and may constitute minimal risk for transfusion associated infections.

Citing Articles

Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria.

Salu O, Akinbamiro T, Orenolu R, Ishaya O, Anyanwu R, Vitowanu O PLoS One. 2024; 19(6):e0305521.

PMID: 38905317 PMC: 11192311. DOI: 10.1371/journal.pone.0305521.


Dynamic and Seasonal Distribution of Enteric Viruses in Surface and Well Water in Riyadh (Saudi Arabia).

Abid I, Blanco A, Al-Otaibi N, Guix S, Costafreda M, Pinto R Pathogens. 2023; 12(12).

PMID: 38133289 PMC: 10747075. DOI: 10.3390/pathogens12121405.


Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis.

Wolski A, Pischke S, Ozga A, Addo M, Horvatits T Pathogens. 2023; 12(3).

PMID: 36986347 PMC: 10059948. DOI: 10.3390/pathogens12030425.


Hepatitis E Virus (HEV) in Makkah, Saudi Arabia: A Population-Based Seroprevalence Study.

El-Daly M, Al-Raddadi R, Alharbi A, Azhar A, Khallaf A, Hassan A Viruses. 2023; 15(2).

PMID: 36851698 PMC: 9964995. DOI: 10.3390/v15020484.


Analysis of seroprevalence and risk factors for hepatitis E virus (HEV) in donation candidates and blood donors in Northeast Brazil.

Cunha G, Bezerra L, Silva Junior J, Goncales J, Montreuil A, Coelho M Braz J Microbiol. 2022; 53(4):1995-2001.

PMID: 36100808 PMC: 9679076. DOI: 10.1007/s42770-022-00816-z.


References
1.
Khuroo M, Khuroo M, Khuroo N . Transmission of Hepatitis E Virus in Developing Countries. Viruses. 2016; 8(9). PMC: 5035967. DOI: 10.3390/v8090253. View

2.
Tsachev I, Baymakova M, Marutsov P, Gospodinova K, Kundurzhiev T, Petrov V . Seroprevalence of Hepatitis E Virus Infection Among Wild Boars in Western Bulgaria. Vector Borne Zoonotic Dis. 2021; 21(6):441-445. DOI: 10.1089/vbz.2020.2756. View

3.
Ibrahim E, Abdelwahab S, Nady S, Hashem M, Galal G, Sobhy M . Prevalence of anti-HEV IgM among blood donors in Egypt. Egypt J Immunol. 2012; 18(2):47-58. View

4.
Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S . Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol. 2013; 5(2):172-6. PMC: 3696855. View

5.
Pelosi E, Clarke I . Hepatitis E: a complex and global disease. Emerg Health Threats J. 2012; 1:e8. PMC: 3167588. DOI: 10.3134/ehtj.08.008. View